Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 12 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Preparation process of transition metal boride and uses thereof
Non-volatile flash-RAM memory with magnetic memory
Stand for food service
Rear body panel cover for a motor vehicle
Computer system for routing package deliveries
Mask and method for forming the mask
Metal melting apparatus and method for melting metal
  Randomly Featured Patents
Piezoelectric actuator and liquid-droplet jetting head
Flame control system for heat exchanger
Implementing a counter offer for an on line credit card application
Electric power generation/hydrogen production combination plant
Circuit for and an electronic device including a nonvolatile memory cell and a process of forming the electronic device
Method and apparatus for catalytic dissociation of NO
Silicone resin coating composition
Low cost die release wafer
Method for producing display device
Method and apparatus for operating multiple security modules